Polyphor is a clinical stage biopharmaceutical company focused on the discovery and development of immuno-oncology compounds and a new class of antibiotics against Gram-negative bacteria, the Outer Membrane Protein Targeting Antibiotics (OMPTA).
-
Swiss Biotech AssociationMember
- Claim / update listing